NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/14/2025
Back to search
Official data from USPTO
GALT PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GALT PHARMACEUTICALS
ST13
US500000087978500Class
35
Filing
87978500
Registration
5608954
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/15/2025
Trademark type
Word
Nice classes
35
Filing date
06/14/2017
Registration date
11/13/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2025
Last transaction
04/15/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
First use anywhere
05/08/2017
First use in commerce
06/15/2018
Drawing code
4
Owner type
16
Owner location
Atlanta, GA
Examiner
MARTIN, LIEF
Current location
Historical data usage
Holders and representatives
Holders
Galt Pharmaceuticals, LLC
Representatives
Chelsea G. Swanson
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Wholesale store services featuring pharmaceutical products; distributorships in the field of prescription drug and pharmaceutical products
Publications
History of USPTO decisions and trademark events.
38 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/14/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/14/2025
ES8R
TEAS SECTION 8 RECEIVED
10/03/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/13/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
11/13/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/09/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
10/02/2018
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/01/2018
IUAA
USE AMENDMENT ACCEPTED
10/01/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
09/27/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
09/12/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/11/2018
IUAF
USE AMENDMENT FILED
09/06/2018
DRRR
DIVISIONAL REQUEST RECEIVED
09/06/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/06/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
09/06/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/20/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/14/2018
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/16/2018
GNFR
FINAL REFUSAL E-MAILED
03/16/2018
CNFR
FINAL REFUSAL WRITTEN
03/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/27/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2018
ALIE
ASSIGNED TO LIE
02/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/14/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/14/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2017
GNRT
NON-FINAL ACTION E-MAILED
09/15/2017
CNRT
NON-FINAL ACTION WRITTEN
09/15/2017
DOCK
ASSIGNED TO EXAMINER
09/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/20/2017
NWAP
NEW APPLICATION ENTERED
06/17/2017
Continuous trademark protection
Get notified about every new filing that threatens GALT PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.